Primary Health To Pay $18m As Total Remediation Cost

Primary Health Care

On 26 October 2018, Primary Health Care Ltd (ASX: PRY) revealed that it will compensate certain past and present employees for incorrect payments under the modern awards since July 2011. The company has identified this issue during a review of its payroll system. The total remediation costs of $18 million will be paid by the company as part of compensation. Following this news, the share price of the company decreased by 5.657 percent as on 26 October 2018.

According to the company’s release the average annual remediation of impacted employees, including superannuation and on-costs, is $400 per person. The company is planning to pay interest on the amounts owed and will not seek recovery of any overpayments identified during the review.

Company’s chief executive Mr. Malcolm Parmenter said the company deeply regret this matter and apologize to the current and former employees of Primary. The company will contact everyone who has been impacted, regardless of the size of the amounts owing, and to remediate the issue as transparently and as soon as possible. [optin-monster-shortcode id=”swikrbu1d9j9aq0o4cko”]

In FY 2018, the company delivered underlying revenue of $1.7 billion which is 4.9% higher than the last year, and the company also reported an underlying net profit after tax of $87.5 million. The Free cash flow during the period increased by over 5 percent to $146.6 million. The Company’s growth expenditure was $76.6 million in FY 2018 which was used primarily to fund the acquisition of BPI and new clinics in Health & Co, fit-out costs and equipment for four new medical centres, an IVF and day surgery in Perth, Kawana Imaging Centre, as well as other hospital and high-end Imaging sites.

The company invested $40.9 million in restructuring and strategic initiatives which delivered cost savings and mitigate risks and recorded $5.1 million of non-recurring items. As a result, the company recorded an FY 2018 statutory profit after tax of $4.1 million, up from the impairment-driven loss of $516.9 million in FY 2017.

The long-term drivers for healthcare are positive as there is a strong underlying demand for healthcare in Australia, underpinned by a growing and ageing population, increasing numbers of people living for longer with chronic illness, rising patient expectations and expanding wealth per capita. It is expected that healthcare delivery in the future will occur more in the home and community facilities rather than inexpensive overnight hospital facilities.

In the recently held annual general meeting, the company included a special resolution to shareholders to approve a change of Company’s name to Healius Limited. As per the company, the new name signifies what the company wants the future to be and central to this future is developing a workplace of choice where engaged and valued people can operate.

In the last six months, the share price of the company decreased by 24.47 percent as on 25 October 2018, traded at a PE level of 161.180x. PRY’s shares traded at $2.585 with a market capitalization of circa $1.7 billion as on 26 October 2018 (AEST 1:57 PM).


The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.

Checkout our Free Dividend Stocks Report

Specially made for income-hungry investors, Invest in growing Franked Dividends an opportunity that should not be missed.

6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report